X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CALCIFIED TISSUE INTERNATIONAL

期刊標題檢索 CALCIFIED TISSU 最新評論: Review Speed: 24.0 | Submission Acceptance Rate: 95.0 Experience S... (2023-07-31)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CALCIFIED TISSUE INTERNATIONAL]您好,您是該頁面的第 31156 位訪客。

期刊簡介
期刊名稱CALCIFIED TISSUE INTERNATIONAL CALCIFIED TISSUE INTERNATIONAL
LetPub Score
6.6
50 ratings
Rate

Reputation
7.6

Influence
5.2

Speed
9.1

期刊簡稱CALCIFIED TISSUE INT
ISSN0171-967X
E-ISSN1432-0827
h-index106
CiteScore
CiteScoreSJRSNIPCiteScore Rank
8.001.0161.195
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Orthopedics and Sports Medicine
Q118 / 321
Category: Medicine
Subcategory: Endocrinology, Diabetes and Metabolism
Q148 / 244
Category: Medicine
Subcategory: Endocrinology
Q129 / 128

自引率 (2023-2024)3.00%自引率趨勢
掲載範囲
Calcified Tissue International and Musculoskeletal Research publishes original research and reviews concerning the structure and function of bone, and other musculoskeletal tissues in living organisms and clinical studies of musculoskeletal disease. It includes studies of cell biology, molecular biology, intracellular signalling, and physiology, as well as research into the hormones, cytokines and other mediators that influence the musculoskeletal system. The journal also publishes clinical studies of relevance to bone disease, mineral metabolism, muscle function, and musculoskeletal interactions.
官方網站https://www.springer.com/223
在線稿件提交https://www.editorialmanager.com/ctin
開放訪問No
出版商Springer US
主題領域医学
出版國/地區UNITED STATES
發行頻率月刊
創刊年1967
每年文章數109每年文章數趨勢
黃金OA百分比34.44%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ENDOCRINOLOGY & METABOLISMSCIEQ277/186
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0171-967X%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Sort of slow, 4-8 Week(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【CALCIFIED TISSUE INTERNATIONAL】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Nature Reviews EndocrinologyH-index: 116

    CiteScore: 42.00
    Cell MetabolismH-index: 219

    CiteScore: 48.60
    ENDOCRINE REVIEWSH-index: 257

    CiteScore: 42.00
    DIABETES CAREH-index: 328

    CiteScore: 29.50
    TRENDS IN ENDOCRINOLOGY AND METABOLISMH-index: 146

    CiteScore: 20.10
    METABOLISM-CLINICAL AND EXPERIMENTALH-index: 122

    CiteScore: 18.90
    Cardiovascular DiabetologyH-index: 64

    CiteScore: 12.30
    DIABETOLOGIAH-index: 207

    CiteScore: 18.10
    JOURNAL OF PINEAL RESEARCHH-index: 113

    CiteScore: 17.70
    Obesity ReviewsH-index: 137

    CiteScore: 19.30
    學科內最受檢索的期刊 頁面查看次數
    FREE RADICAL BIOLOGY AND MEDICINE191554
    Cell Metabolism129840
    DIABETES101910
    JOURNAL OF PINEAL RESEARCH97565
    BIOLOGICAL TRACE ELEMENT RESEARCH92853
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM81288
    ANTIOXIDANTS & REDOX SIGNALING79907
    DIABETES CARE73447
    BONE70434
    Obesity68336
  •  

    CALCIFIED TISSUE INTERNATIONAL CALCIFIED TISSUE INTERNATIONAL
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [CALCIFIED TISSUE INTERNATIONAL] 的評論撰寫評論
作者: Amanda Tate


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-31 08:31:20 評論於
Review Speed: 24.0 | Submission Acceptance Rate: 95.0
Experience Share: This is a terrible magazine. I submitted my article and after half a month, it was still under review by the editor. I couldn't wait any longer so I sent an email to inquire about the status. They immediately rejected my submission, saying it did not meet the journal's requirements. I just want to ask, if it didn't meet the requirements, did you really need to wait a whole month? As soon as the author inquired via email, you immediately rejected the submission? This magazine is unreliable and always puts itself above the authors
(0) 讚! | Amanda Tate

作者: 通幽乐珍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-26 23:33:50 評論於
It has been almost a month for me
(0) 讚! | 通幽乐珍

作者: 一只雅歌呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-04 11:29:42 評論於
How long will it last?
(0) 讚! | 一只雅歌呀

作者: 碧水冬荷


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-07 08:02:19 評論於
How long will Reviewers Assigned last?
(0) 讚! | 碧水冬荷

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 22:45:36 評論於
For example, experimental techniques such as PCR, Western blot, and the usage methods of some instruments
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 13:26:04 評論於
The general advice is to follow this order
(0) 讚! | 维尔娜菲茨杰拉德

作者: Oswald Edie


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 21:01:55 評論於
Do methods have to be written in the order of results?
(0) 讚! | Oswald Edie

作者: 平原文波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 23:34:47 評論於
What is the standard use method of the laboratory?
(0) 讚! | 平原文波

作者: 雨巷少年喜云


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-03-20 09:53:39 評論於
How much is the layout fee?
(0) 讚! | 雨巷少年喜云

作者: 摔碑元斐


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-01-27 13:52:52 評論於
Can you please talk about the convenience of AS from any aspect?
(0) 讚! | 摔碑元斐

作者: 以冬少女


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-03-16 11:01:52 評論於
Review Speed: 2.0 | Submission Hit Rate: 75.0
Experience Sharing: Submitted on December 20, 2018, received revision comments on January 28, major revision, resubmitted on February 20, accepted on March 13
(0) 讚! | 以冬少女

作者: 碧桃逸致


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-01-11 23:48:14 評論於
Review speed: 3.0 | Submission acceptance rate: 25.0
Experience sharing: This journal is getting better and better. The impact factor has been rising in recent years, which is a good sign. I recently submitted two papers and received very valuable feedback from the reviewers
(0) 讚! | 碧桃逸致

作者: Obal


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2019-01-11 17:11:47 評論於
This journal is getting better and better. The impact factor in recent years have been rising. It is a good proof. Recently, two of them have been submitted. The reviewers gave very good opinions

(0) 讚! | Obal

作者: Pearl Malachi


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-12-07 20:49:05 評論於
Is this magazine accepting reviews?
(0) 讚! | Pearl Malachi

作者: 北海哲玮


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-06-26 18:20:30 評論於
Do we need to provide the original data for this magazine?
(0) 讚! | 北海哲玮

作者: 灵空凡海


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-01-11 21:58:17 評論於
Is there a layout fee for this?
(0) 讚! | 灵空凡海

作者: 宗室向凝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-08-24 19:41:34 評論於
Do you charge a layout fee? How is it calculated?
(0) 讚! | 宗室向凝

作者: 宗室向凝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-08-17 14:08:28 評論於
How is the layout fee calculated?
(0) 讚! | 宗室向凝

作者: 宗室向凝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-08-06 08:30:27 評論於
Do you need to pay layout fees?
(0) 讚! | 宗室向凝

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-18 19:54:45 評論於
3 points edge, hoping to remain stable, a slight increase is also good
(0) 讚! | 凌霄高洁

作者: 风见修永


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-03-03 16:59:39 評論於
But the review process takes too long, I need this article to graduate soon, it seems like I can't submit it
(0) 讚! | 风见修永

作者: 神古苑博


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-03-01 11:35:28 評論於
Agree with this opinion! Osteoporosis is more popular. Chinese people published 3 papers in 2012, 4 in 2013, and it increased to 12 in 2014, very fast!
(0) 讚! | 神古苑博

作者: 风见修永


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2015-03-01 08:06:55 評論於
Do you have any experience submitting articles in recent years?
(0) 讚! | 风见修永

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [CALCIFIED TISSUE INTERNATIONAL] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*